Literature DB >> 8968878

Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells.

M Kameoka1, T Kimura, Y H Zheng, S Suzuki, K Fujinaga, R B Luftig, K Ikuta.   

Abstract

Apoptosis and syncytium formation are two mechanisms by which human immunodeficiency virus type 1 (HIV-1) impairs uninfected CD4+ T-cell function and are mainly involved in the progression of the disease to AIDS. Previously, we showed that gp120-containing, protease-deficient HIV-1 (L-2) particles generated syncytia by particle-mediated fusion with uninfected cultured CD4+ T cells. Here, we present evidence that such L-2 particles can induce apoptosis in 40 to 50% of T cells which were enriched from HIV-1-negative healthy donor-derived peripheral blood mononuclear cells (PBMC-Ts). Activation of PBMC-Ts with phytohemagglutinin, concanavalin A, or ionomycin after incubation with L-2 particles resulted in the loss of proliferative capacity and gradual induction of apoptosis over 3 days. Wild-type strain LAI particles or recombinant gp120 were markedly less efficient (< or = 15%) at inducing such apoptosis. Western blot (immunoblot) analysis revealed that L-2 particles contained a larger amount of Env gp120 than LAI particles. Either preincubation of PBMC-Ts with a Fas antagonist or preincubation of L-2 particles with soluble CD4 blocked most of the apoptosis. This suggests that L-2-like particles can play a major role in HIV-1-induced apoptosis of uninfected bystander cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8968878      PMCID: PMC229509          DOI: 10.1128/jcm.35.1.41-47.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

2.  Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells.

Authors:  T Nakaya; K Fujinaga; M Kishi; S Oka; T Kurata; I M Jones; K Ikuta
Journal:  FEBS Lett       Date:  1994-10-31       Impact factor: 4.124

3.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.

Authors:  C J Li; D J Friedman; C Wang; V Metelev; A B Pardee
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

Review 4.  Fas and FasL in the homeostatic regulation of immune responses.

Authors:  D H Lynch; F Ramsdell; M R Alderson
Journal:  Immunol Today       Date:  1995-12

5.  Quantitation of matrix Gla protein mRNA by competitive polymerase chain reaction using glyceraldehyde-3-phosphate dehydrogenase as an internal control.

Authors:  J Zhao; N Araki; S K Nishimoto
Journal:  Gene       Date:  1995-04-03       Impact factor: 3.688

6.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

7.  Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1.

Authors:  F Maldarelli; H Sato; E Berthold; J Orenstein; M A Martin
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells.

Authors:  S J Martin; P M Matear; A Vyakarnam
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

9.  Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells.

Authors:  M Kishi; Y H Zheng; M K Bahmani; K Tokunaga; H Takahashi; M Kakinuma; P K Lai; M Nonoyama; R B Luftig; K Ikuta
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

View more
  10 in total

1.  Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

Authors:  M T Esser; J W Bess; K Suryanarayana; E Chertova; D Marti; M Carrington; L O Arthur; J D Lifson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 2.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

3.  Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.

Authors:  Geoffrey H Holm; Dana Gabuzda
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase.

Authors:  M Kameoka; K Ota; T Tetsuka; Y Tanaka; A Itaya; T Okamoto; K Yoshihara
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

5.  Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env.

Authors:  Michael J Lenardo; Sara B Angleman; Viengngeun Bounkeua; Joseph Dimas; Melody G Duvall; Moses B Graubard; Felicita Hornung; Marianne C Selkirk; Christina K Speirs; Carol Trageser; Jan O Orenstein; Diane L Bolton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.

Authors:  Satoshi Komoto; Shoutaro Tsuji; Madiha S Ibrahim; Yong-Gang Li; Jiranan Warachit; Koki Taniguchi; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.

Authors:  Wendy Fitzgerald; Andrew W Sylwester; Jean-Charles Grivel; Jeffrey D Lifson; Leonid B Margolis
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virions.

Authors:  A W Sylwester; J C Grivel; W Fitzgerald; J L Rossio; J D Lifson; L B Margolis
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.

Authors:  Xiaozhuo Ran; Zhujun Ao; Adriana Trajtman; Wayne Xu; Gary Kobinger; Yoav Keynan; Xiaojian Yao
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

10.  HIV integrase and the swan song of the CD4 T cells?

Authors:  Jérôme Estaquier; John Zaunders; Mireille Laforge
Journal:  Retrovirology       Date:  2013-12-09       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.